You searched for "disease"

2340 results found

Orbis UK release 2024 highlights video

Orbis UK have released their 2024 highlights video, revealing some of the incredible achievements their supporters helped make possible last year. The Orbis Flying Eye Hospital completed two sight-saving missions to Mongolia and Bangladesh. Orbis's clinical staff and Volunteer medical...

Optical Coherence Tomography: A Clinical and Technical Update

This book is a comprehensive review of the clinical and scientific aspects of optical coherence tomography (OCT). The 255 pages are divided into 11 chapters, each written by a different group of authors. Part I provides viewpoints on the clinical...

Fingolimod: ocular adverse effects

In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....

Adjuvant intravitreal dexamethasone implant for persistent CME

In this retrospective, cross-sectional study the authors investigate the efficiency of intravitreal dexamethasone implants (0.7mg) for cystoid macular oedema (CME) persisting, despite immunomodulatory treatment in patients with Behcets’ disease (BD). Twenty-seven eyes of 20 patients (12 males and eight females)...

Sex hormones in males and females with central serous chorioretinopathy

This study was aimed to assess the role of sex hormones in male and female patients with central serous chorioretinopathy (CSC), a disease with a pronounced male predilection. Two hundred and six patients, 183 males (mean age 52, median 52,...

The Worshipful Company of Spectacle Makers awards two Master’s Medals for early career research

The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of two Master’s Medals for 2025. Fabian Yii from Edinburgh was awarded the Master’s Medal for his paper, 'Fundus Refraction Offset as a Personalized Biomarker for 12-Year Risk...

Outcome of patients undergoing immediate sequential bilateral vitreoretinal surgery

This was a multicentre retrospective review of a case series from patients undergoing immediate sequential bilateral vitreoretinal surgery (ISBVS). A proforma was circulated to ophthalmic surgeons across the UK for cases of this rarely performed approach to collate indications, operative...

New service offers advanced diagnostics, early detection and reassurance

Centre for Sight, the UK’s leading trusted centre of excellence for advanced eye care, has launched a new Eye Health MOT service for people aged 40 and over, offering a detailed, consultant-led assessment designed to provide reassurance and detect early...

Everyday diabetes medicine could treat common cause of blindness

Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western countries. People with diabetes over the age of 55 years taking metformin were...

The friendly face of ophthalmology

The friendly face of ophthalmology

Commonwealth nations join forces to prevent blindness from diabetes

More than 70 representatives from 10 Commonwealth countries (in the African, Caribbean and Pacific regions) and Indonesia gathered at a five-day workshop in November 2014 to establish district or national plans to reduce blindness from diabetic retinopathy (DR). The event...

Cambridge Ophthalmological Symposium 2024: Evolution and the Eye

by Anushka Irodi, Y5 Medical Student, University of Cambridge, UK. The 52nd Cambridge Ophthalmological Symposium, a renowned two-day national meeting, took place on September 5th and 6th, 2024 at St John’s College, Cambridge, UK. It brought together international leading minds...